Fevertree Drinks (LSE:FEVR) reported Fever-Tree brand revenue of £183.6 million for the six months ended 30 June 2026, an increase of 8% at constant currency, with growth recorded across all regions.
The company said the brand achieved record retail market shares in ginger beer and tonic during the period.
In the U.S., Fevertree reported increased activity under its partnership with Molson Coors. The UK business returned to revenue growth, with the company citing higher off-trade sales and favourable summer weather during the period.
Products outside the group’s tonic range continued to account for a greater proportion of sales, with the wider portfolio representing almost half of group revenue.
Adjusted EBITDA Rises 9%
Adjusted EBITDA increased 9% to £20.1 million, while the adjusted EBITDA margin rose to 10.9%.
Diluted earnings per share increased 38% compared with the corresponding period a year earlier.
Fevertree also announced a new £60 million share buyback programme following the completion of a £100 million programme in 2025.
The company maintained its full-year guidance.
More about Fevertree Drinks
Fevertree Drinks plc produces mixers and soft drinks, including tonic waters, ginger beer and flavoured sodas.
The company operates across markets including the UK, U.S., Europe and other international regions, selling products for use in both alcoholic and non-alcoholic drinks.
Its product portfolio has expanded beyond tonic water to include ginger beer, sodas and other mixer categories.
SEO
Focus keyphrase: Fevertree H1 2026 results
Meta description: Fevertree reports H1 brand revenue of £183.6 million, up 8% at constant currency, while adjusted EBITDA rises 9% to £20.1 million.
Leave a Reply